Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor-Reference-Cited by-同舟云学术

Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor

Published:2022-10 Issue:10 Volume:40 Page:455.e11-455.e18
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Yukihiro Kazuma,Teishima Jun,Goto Keisuke,Aoki Gaku,Sekino Yohei,Hayashi Tetsutaro,Hasegawa Yasuhisa,Mita Koji,Kato Masao,Kajiwara Mitsuru,Shigeta Masanobu,Maruyama Satoshi,Kadonishi Yuichi,Fujiwara Seiji,Hinata Nobuyuki

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference36 articles.

1. National Cancer Institute. Seer cancer STAT facts: kidney and renal pelvis cancer, 2020. Available at: https://seer.cancer.gov/statfacts/html/kidrp.html

2. Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era;Pal;PLoS One,2013

3. Real-world survival outcomes and prognostic factors among patients receiving first targeted therapy for advanced renal cell carcinoma: A SEER-medicare database analysis;Pal;Clin Genitourin Cancer,2017

4. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

5. Pazopanib versus sunitinib in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels;2024-06-25

2. Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective study;Hematological Oncology;2023-09-20